Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at 68Ga-DOTANOC PET/CT imaging-Reference-Cited by-同舟云学术

Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at 68Ga-DOTANOC PET/CT imaging

Published:2017-07-07 Issue:2 Volume:57 Page:283-289
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Ruuska Tiina¹²^ORCID,Ramírez Escalante Yadith³,Vaittinen Samuli⁴,Gardberg Maria⁵,Kiviniemi Aida⁶,Marjamäki Päivi²,Kemppainen Jukka²⁷,Jyrkkiö Sirkku⁸,Minn Heikki²⁸

Affiliation:

1. University of Turku, Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland;

2. Turku PET Centre, Turku University Hospital, University of Turku, Turku, Finland;

3. Department of Nuclear Medicine, La Paz University Hospital, Madrid, Spain;

4. Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland;

5. Department of Pathology, Turku University Hospital, Turku, Finland;

6. Department of Radiology, Medical Imaging Centre of Southwest Finland, Turku University Hospital, Turku, Finland;

7. Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland;

8. Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland

Funder

Finnish Cancer Foundation

Finnish Society for Oncology

Turku University Society

Turku University Hospital Research Funds

Turun Suomalainen Yliopistoseura

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2017.1342864

Reference24 articles.

1. Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE

2. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

3. Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours

4. 68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors

5. Somatostatin analogue scintigraphy of malignant lymphomas

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias;Current Issues in Molecular Biology;2024-09-02

2. Mesenteric Pathologic Conditions: Interactive Case-based Approach;RadioGraphics;2023-12-01

3. Evaluation of [⁶⁸Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space;Journal of Nuclear Medicine;2023-06-29

4. 68Ga-DOTATATE PET/CT Incidentally Detects Relapsed Chronic Lymphocytic Leukemia in Patient With Metastatic Neuroendocrine Tumor;Clinical Nuclear Medicine;2022-09-06

5. Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature;Cancer Imaging;2022-09-03